Development and validation of a method for the quantitative determination of marbofloxacin in the substance and drug "Marbotim" in the form of a solution for injection
https://doi.org/10.52419/issn2072-2419.2025.3.114
Abstract
The aim of this work was to develop and validate a method for the quantitative determination of marbofloxacin in the substance and the medicinal product "Marbotim" in the form of an injection solution using highperformance liquid chromatography. The following tasks were solved in the course of the work: to develop methods for the quantitative determination of marbofloxacin in the substance and medicinal products based on it, to validate the method for the quantitative determination of marbofloxacin in the substance and in the preparation "Marbotim" in the form of an injection solution. The quantitative content of marbofloxacin was determined using high-performance liquid chromatography according to OFS.1.2.1.2.0005 or FEAEC 2.1.2.28 [4]. The work used the analytical standard sample of marbofloxacin series G1297125 (DR. EHRENSTORFER) with the content of the active substance of 99.28%, acetonitrile (Alpha Chemika, India), trifluoroacetic acid (Central Drug House, India), glacial acetic acid (SigmaAldrich, USA) and ultrapurified water obtained using the Rephile Genie U device that produces ultrapure water (type I water) and reverse osmosis water (type III water) (China). Validation was carried out according to OFS.1.1.0012. A 0.1% (vol.) solution of acetic acid was used as a solvent. The standard solution of marbofloxacin, test solutions of marbofloxacin substance and the medicinal product "Marbotim" were prepared using a solvent (0.1% acetic acid solution) and with a final concentration of marbofloxacin - 16 μg / ml. Based on the results of testing for the parameters: specificity, linearity, convergence, intralaboratory precision, accuracy, analytical range, robustness, the methods for the quantitative determination of marbofloxacin in the substance and the medicinal product "Marbotim" in the form of an injection solution were assigned the status "Validated".
About the Authors
K. E. BobkovaRussian Federation
senior analytical chemist
Y. E. Kuznetsov
Russian Federation
doctor of veterinary medicine sciences, Associate Professor
References
1. Bero R., Castillo J.D., Geneault L. The problem of antibiotic resistance // "Veterinarian". - 2008. - No. 2. - P. 28-35.
2. Correlation relationships between the content of total bile acids and the main biochemical parameters of blood in minks (Mustela vison Schreber, 1777) / Yu. E. Kuznetsov, A. M. Lunegov, V. S. Ponomarev, E. B. Romashova // Agricultural biology. - 2022. - Vol. 57, No. 6. - P. 1217-1224. - DOI 10.15389/agrobiology.2022.6.1217rus. - EDN FIAAST.
3. Kuznetsov, Yu. E. Subchronic toxicity of the drug Azidox / Yu. E. Kuznetsov // International Bulletin of Veterinary Medicine. - 2016. - No. 2. - P. 19-24. - EDN WCNTSZ.
4. Methodical instructions M3 and SR RF from 10.08.2004. Conducting qualitative studies of bioequivalence of drugs // Clinical pharmacokinetics. - 2005. - No. 1 (2). - P. 2- 9.
5. Subbotin V.V., Danilevskaya N.V. Antibacterial therapy in veterinary practice // "Veterinary sciences". - 2011. - No. 1. - P. 38-42.
6. Mostovoy Y., Demchuk A., Konstantynovych T., Chichirelo-Konstantynovych K. Chronic comorbidity of internal organs as a risk factor of complications and fatal outcome of community-acquired pneumonia // «The Journal of Nutrition, Health & Aging». – 2018. – No. 3. – P. 42-48.
7. Order of the Ministry of Agriculture of the Russian Federation dated 06.03.2018 No. 101 «On approval of the rules for conducting a preclinical study of a medicinal product for veterinary use, a clinical study of a medicinal product for veterinary use, a bioequivalence study of a medicinal product for veterinary use.
8. Khabriev R.U. Guidelines for experimental (preclinical) study of new pharmacological drugs. 2nd ed., revised and add. Moscow: OJSC "Izdatelstvo" Medicine ", 2005. 832 p.
9. Yakovlev S.V. Antibiotics in outpatient practice: some problems // "Clinical pharmacology and therapy". - 2000. - No. 2. - P. 3- 24.
Review
For citations:
Bobkova K.E., Kuznetsov Y.E. Development and validation of a method for the quantitative determination of marbofloxacin in the substance and drug "Marbotim" in the form of a solution for injection. International Journal of Veterinary Medicine. 2025;(3):114-124. (In Russ.) https://doi.org/10.52419/issn2072-2419.2025.3.114
JATS XML


















